Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07100197

EEG-TMS Intervening Against Postoperative Delirium

EEG-TMS Intervening Against Postoperative Delirium in Elderly Patients: A Randomized Clinical Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
98 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Postoperative delirium is common in elderly surgical patients and is associated with complications and prolonged hospitalisation. The aim of the RECOVER study is to assess the efficacy of electroencephalo graph (EEG)-transcranial magnetic stimulation (TMS) treatment for the management of postoperative delirium.

Detailed description

Postoperative delirium(POD), a syndrome characterized by an acute change in attention, awareness and cognition, is one of the most common postoperative complications among elderly patients. Impaired neuronal network connectivity is likely one of the several neurobiological processes that contribute to POD pathogenesis. Recently, continuous theta burst stimulation (cTBS), a pattern of TMS, was demonstrated to improve cognitive function in patients with mild cognitive impairment.Recent research suggests that cTBS has positive effect on improving the connectivity and reorganization of the brain network.This project team conducted a pilot study in the early stage and innovatively applied cTBS to treat postoperative delirium in elderly patients. The results preliminarily elucidate the safety, and feasibility of TMS in treating postoperative delirium in elderly patients. In order to confirm the effectiveness of EEG-TMS therapy for POD and observe its impact on long-term prognosis, this project will conduct a prospective randomized controlled study to compare TMS therapy with sham stimulation therapy. The study will observe The duration of postoperative delirium during the 7-day intervention period, as well as severity of delirium, the time to successful discharge (defined as the patient surviving outside the hospital for at least 48 hours after discharge), and the 30-day and 90-day survival times, the number of patients receiving salvage drug treatment, and the number of days each patient received salvage drug treatment, the sensitivity, specificity, and predictive value of EEG. The trial will provide new ideas for the prediction and treatment of postoperative delirium in clinic.

Conditions

Interventions

TypeNameDescription
DEVICEcontinuous Theta-burst stimulationTreatment parameters: each cTBS session consists of 50 Hz triplets of pulses delivered at 5 Hz for 40 s, totaling 600 pulses, and every set simulation includes 3 sessions. Electrodes are attached to designated head regions (right dorsolateral prefrontal cortex).
DEVICEShamthe treatment mode was with sham coil.

Timeline

Start date
2025-07-27
Primary completion
2026-10-30
Completion
2027-01-30
First posted
2025-08-03
Last updated
2025-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07100197. Inclusion in this directory is not an endorsement.